Abstract:

      In December 27, 2013, the 2^nd “China Medical Development Forum”, A.K.A. the Seminar of Drug Quality and Market Access, jointly managed by Peking University International Research Center of Medicinal Administration(IRCMA) and Center for Research and Development of Medications (CRDM) was ceremoniously held in Peking University Health Science Center (PHUSC). Prof. Mingli Shao, the original director of State Food and Drug Administration (SFDA) and Prof. Yang Ke, associated president of university, government managers, university scholars, hospital pharmacists, and experts of IRCMA and CRDM attended the forum. 
      At the start of the forum, Prof. Yang Ke delivered a speech on behalf of PHUSC. She pointed out that drug quality and market access have a close contact with healthcare reform, experts and scholars’ participation will contribute a lot to the reform of drug safety. She emphasized that the quality of drug depended on the quality of design, which made drug safety related to multiple steps, more and more practice proved that multidiscipline and a combination of natural and social sciences could indeed solve problems related to medical, healthcare system, and human health. Finally, she put forward the hope of long-term development of the forum. Prof. Mingli Shao also delivered a speech representing academic advisers of IRCMA, highly praised the efforts and achievements the IRCMA had made on ensuring drug safety, rational use of medications, and promoting the healthy development of pharmaceutical industry. He thanked the support from PUHSC to IRCMA.